The Priority Review

Tag

IRMA

1 story

Stories

  1. Clinical trials

    IRMA trial reports 5-year local control for partial-breast irradiation

    The authors reported a 5-year cumulative ipsilateral breast tumor recurrence of 1.0% (95% CI, 0.6 to 1.6) for APBI versus 0.8% (95% CI, 0.5 to 1.4) for WBI. The hazard ratio for APBI versus WBI was 1.18 (90% CI, 0.63 to 2.20), with the upper confidence limit crossing the prespecified noninferiority margin.